From the insoluble dye indirubin towards highly active, soluble CDK2-inhibitors

被引:77
作者
Jautelat, R [1 ]
Brumby, T
Schäfer, M
Briem, H
Eisenbrand, G
Schwahn, S
Krüger, M
Lücking, U
Prien, O
Siemeister, G
机构
[1] Schering AG, Med Chem, Res Ctr Europe, D-13342 Berlin, Germany
[2] Schering AG, ET Struct Biol, Res Ctr Europe, D-13342 Berlin, Germany
[3] Schering AG, CDCC Computat Chem, Res Ctr Europe, D-13342 Berlin, Germany
[4] Univ Kaiserslautern, Dept Chem, Div Food Chem & Environm Toxicol, D-67663 Kaiserslautern, Germany
[5] Schering AG, Corp Res, Expt Oncol, D-13342 Berlin, Germany
关键词
biological activity; enzymes; medicinal chemistry; natural products; structure-activity relationships;
D O I
10.1002/cbic.200400108
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In search of novel antitumor therapies. The natural product indirubin (1) is one of the class of indigo dyes, insoluble in aqueous systems, employed by mankind since the Bronze Age for textile coloring. In 1999 indirubin was reported to be a modest inhibitor of the enzyme CDK2, a key target in the ongoing search for novel antitumor therapies. With the guidance of X-ray structures, indirubin was transformed to yield novel, soluble, almost colorless, highly potent CDK2 inhibitors that strongly inhibit the growth of the MCF7 tumor cell line in vitro. © 2005 Wiley-VCH Verlag GmbH & Co. KGaA.
引用
收藏
页码:531 / 540
页数:10
相关论文
共 29 条
  • [1] Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine
    Adachi, J
    Mori, Y
    Matsui, S
    Takigami, H
    Fujino, J
    Kitagawa, H
    Miller, CA
    Kato, T
    Saeki, K
    Matsuda, T
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (34) : 31475 - 31478
  • [2] Balfour-Paul Jenny, 1998, INDIGO
  • [3] The aryl hydrocarbon receptor in anticancer drug discovery: Friend or foe?
    Bradshaw, TD
    Trapani, V
    Vasselin, DA
    Westwell, AD
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (27) : 2475 - 2490
  • [4] CONWAY SC, 1990, HETEROCYCLES, V30, P627
  • [5] Inhibitor binding to active and inactive CDK2: The crystal structure of CDK2-cyclin A/indirubin-5-sulphonate
    Davies, TG
    Tunnah, P
    Meijer, L
    Marko, D
    Eisenbrand, G
    Endicott, JA
    Noble, MEM
    [J]. STRUCTURE, 2001, 9 (05) : 389 - 397
  • [6] DEGRADATIVE ROUTES TO ELECTROPHILIC CD-SUBSTRUCTURES OF TAXOL
    DIGRANDI, MJ
    COBURN, CA
    ISAACS, RCA
    DANISHEFSKY, SJ
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 1993, 58 (27) : 7728 - 7731
  • [7] Gu Y C, 1989, Yao Xue Xue Bao, V24, P629
  • [8] Aryl hydrocarbon receptor response to indigoids in vitro and in vivo
    Guengerich, FP
    Martin, MV
    McCormick, WA
    Nguyen, LP
    Glover, E
    Bradfield, CA
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2004, 423 (02) : 309 - 316
  • [9] HIGHLIGHT ON THE STUDIES OF ANTICANCER DRUGS DERIVED FROM PLANTS IN CHINA
    HAN, R
    [J]. STEM CELLS, 1994, 12 (01) : 53 - 63
  • [10] Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases
    Hoessel, R
    Leclerc, S
    Endicott, JA
    Nobel, MEM
    Lawrie, A
    Tunnah, P
    Leost, M
    Damiens, E
    Marie, D
    Marko, D
    Niederberger, E
    Tang, WC
    Eisenbrand, G
    Meijer, L
    [J]. NATURE CELL BIOLOGY, 1999, 1 (01) : 60 - 67